Skip to main content

Animations

MJFF Publications

451 - 460 of 6451 Results
Title
Year
  • Year
  • 2022
  • 2020
  • 2020
  • 2021
  • 2020
  • 2021
  • 2020
  • 2022
  • 2020
  • 2020
  • Summary Details
    OPEN
    Title: Neurological outcomes 1 year after COVID‐19 diagnosis: A prospective longitudinal cohort study
    Journal Name: European Journal of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1111/ene.15307
    Citation Count: 114
  • Summary Details
    OPEN
    Title: Minimalist approaches to cancer tissue-of-origin classification by DNA methylation
    Journal Name: Modern Pathology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41379-020-0547-7
    Citation Count: 38
  • Summary Details
    OPEN
    Title: Virus Bioresistor (VBR) for Detection of Bladder Cancer Marker DJ-1 in Urine at 10 pM in One Minute
    Journal Name: Analytical Chemistry
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acs.analchem.0c00534
    Citation Count: 30
  • Summary Details
    OPEN
    Title: Parkinsonism as a Sequela of SARS‐CoV‐2 Infection: Pure Hypoxic Injury or Additional COVID‐19‐Related Response?
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28656
    Citation Count: 23
  • Summary Details
    OPEN
    Title: A Gain‐of‐Function Mutation in KCNMA1 Causes Dystonia Spells Controlled With Stimulant Therapy
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28138
    Citation Count: 37
  • Summary Details
    OPEN
    Title: Multi‐cohort profiling reveals elevated CSF levels of brain‐enriched proteins in Alzheimer’s disease
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/acn3.51402
    Citation Count: 54
  • Age at Onset of Parkinson’s Disease Among Ashkenazi Jewish Patients: Contribution of Environmental Factors, LRRK2 p.G2019S and GBA p.N370S Mutations
    2020
    Summary Details
    OPEN
    Title: Age at Onset of Parkinson’s Disease Among Ashkenazi Jewish Patients: Contribution of Environmental Factors, LRRK2 p.G2019S and GBA p.N370S Mutations
    Journal Name: Journal of Parkinson's Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.3233/jpd-191829
    Citation Count: 37
  • Summary Details
    OPEN
    Title: Pathological α-synuclein recruits LRRK2 expressing pro-inflammatory monocytes to the brain
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-021-00509-5
    Citation Count: 62
  • Impulse control and related behaviors in Parkinson’s disease with dementia
    2020
    Summary Details
    OPEN
    Title: Impulse control and related behaviors in Parkinson’s disease with dementia
    Journal Name: European Journal of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/ene.14169
    Citation Count: 22
  • Summary Details
    OPEN
    Title: Exosome markers of LRRK2 kinase inhibition
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-020-00138-7
    Citation Count: 23
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.